Overexpression of lncRNA CASC2 inhibits the tumorigenesis of thyroid cancer via sponging miR-24-3p.
Year: 2020
Type: article
Abstract: BACKGROUND: The incidence of thyroid cancer continues to rise all over the world. Thus, it is urgent to find a novel strategy for the treatment of thyroid cancer. Previous reports have confirmed that lncRNA CASC2 is involved in the pathogenesis of thyroid cancer. However, the mechanism by which CASC2 mediates the tumorigenesis of thyroid cancer remains unclear. METHODS: . RESULTS: . CONCLUSION: . Thus, CASC2 may serve as a novel target for the treatment of thyroid cancer.
Source: PubMed Central
Institution: Second Hospital of Hebei Medical University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W3101651829
